₹ 37.90
0.22 (0.58%)
BSE
S
Sandu Pharmaceuticals
₹ 37.90
BSE
Sandu Pharmaceuticals EPS Summary (consolidated)
The latest quarterly EPS of Sandu Pharmaceuticals as of Q4 Mar 2025 stands at ₹0.34. This is a 40.35% fall quarter on quarter and 45.16% fall same quarter last year. For the FY2025 the EPS of Sandu Pharmaceuticals stands at ₹1.60. This is a 5.96% growth compared with FY2024.
Sandu Pharmaceuticals EPS
EPS by Peers

S
Sun Pharmaceutical

D
Divis Laboratories

T
Torrent Pharmaceuticals

L
Laurus Labs

Z
Zydus Life Science
*Based on consolidated figures.

Pay Zero Brokerage on Delivery
Open FREE Demat Account
+91
Or Scan the QR Code to download the Dhan App

